Printer Friendly

NORTH AMERICAN BIOLOGICALS INCREASES PLASMA COLLECTION CAPABILITIES

NORTH AMERICAN BIOLOGICALS INCREASES PLASMA COLLECTION CAPABILITIES
 MIAMI, June 9 /PRNewswire/ -- North American Biologicals, Inc. (NASDAQ: NBIO) ("NABI") today announced it has agreed to acquire and has already assumed operating control of seven plasma collection centers to meet rising demand in the plasma market. In addition, NABI has obtained exclusive rights for plasma produced at six additional centers to service customers of the Biologicals Division of Continental Pharma Cryosan, Inc. which NABI acquired in March of this year. NABI now owns or has rights to plasma produced at 51 centers in 24 states.
 "We are witnessing a significant upsurge in demand for plasma as exemplified by our increase in sales during the first quarter," said David Gury, NABI's president, chairman and CEO. "The focus must now be on supplying that demand. We are, therefore, extremely pleased at the opportunity to increase our collection capability through this acquisition."
 The seven centers located in Kentucky, Tennessee, and Texas. Terms for the cash acquisition were undisclosed.
 Based on NABI's recent experience in acquiring plasma collection centers, the company believes it will be able to significantly improve the productivity of the seven centers. NABI's plans for the centers are to maintain current operating management, and to integrate operating efficiencies currently found in NABI's national collection network.
 North American Biologicals, Inc., headquartered in Miami, Fla., is the world's largest independent provider of human blood plasma elements to the health care industry, one of the largest AIDS screening laboratories in the world, and a leading supplier of control products used to ensure accuracy in blood testing laboratories.
 -0- 6/9/92
 /CONTACT: David J. Gury, president, or Alfred J. Fernandez, VP of finance, of North American Biologicals, 305-625-5303; or Lori Martin of Feinstein Partners, 617-577-8110, for NABI/
 (NBIO) CO: North American Biologicals, Inc. ST: Florida IN: MTC SU:


SH -- NE002 -- 8214 06/09/92 08:39 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 9, 1992
Words:311
Previous Article:ARBUTAMINE PHASE 2 CLINICAL DATA ABSTRACT PUBLISHED IN JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
Next Article:NETMANAGE SHIPS FIRST WINDOWS TCP/IP STACK COMPLIANT WITH 'WINDOWS SOCKETS' SPECIFICATION
Topics:


Related Articles
NORTH AMERICAN BIOLOGICALS TO ACQUIRE INTERNATIONAL BIOLOGICALS BUSINESS AND ALL OUTSTANDING STOCK HELD BY ITS CONTROLLING SHAREHOLDER
NORTH AMERICAN BIOLOGICALS LAUNCHES EXPANSION PROGRAM TO MEET RISING DEMAND FOR PLASMA PRODUCTS
NORTH AMERICAN BIOLOGICALS REPORTS FIRST QUARTER 1992 RESULTS
NORTH AMERICAN BIOLOGICALS, INC. AWARDED $45 MILLION EUROPEAN CONTRACT: PLASMA ORDER IS LARGEST IN NABI'S HISTORY
NORTH AMERICAN BIOLOGICALS, INC. ANNOUNCES THIRD QUARTER AND YEAR-END 1992 OUTLOOK
NORTH AMERICAN BIOLOGICALS, INC. REPORTS FIRST QUARTER 1993 RESULTS; RETURNS TO PROFITABILITY
NORTH AMERICAN BIOLOGICALS RECEIVES FDA LICENSE FOR NEW BIOMEDICAL CENTER - $1.7 MILLION IN PLASMA SHIPMENTS FROM OKLAHOMA SITE UNDERWAY
NORTH AMERICAN BIOLOGICALS TO ACQUIRE MAJOR PLASMA COMPANY
NORTH AMERICAN BIOLOGICALS COMPLETES ACQUISITION OF MAJOR PLASMA COMPANY
NORTH AMERICAN BIOLOGICALS, INC. LAUNCHES EUROPEAN OPERATIONS WITH ACQUISITION OF GERMAN PLASMA FACILITIES

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters